As the NHS approaches its 80th anniversary, what opportunities do digital solutions present for transforming health services, including enhancing staff experiences, streamlining corporate services, and improving patient workflows while also safeguarding digital infrastructures and reducing costs?
Prof Dr Susanne M Bailer, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, explains the possibilities of an oncolytic virus platform technology.
Dr Stephen Barnhill MD, CEO of Apollon Formularies Plc, examines medical cannabis and the future of cancer treatments across the UK and the European healthcare sectors.
Ivan Toplak, Professor from the University of Ljubljana, Veterinary Faculty, reveals what we know about honeybee viral strains and transmission between honeybee colonies.
Pascale V Guillot, Associate Professor at University College London, investigates the possibility of exosome therapy for those living with brittle bone disease.
Clarifying what kind of support is provided by universities in Scotland, as ‘Corporate Parents’, to children and young people who have experienced social care in the UK in comparison with Japan.
Nicola Hemmings, workplace scientist at Koa Health, and Dr Claire Vowell, lead psychologist, discuss how mental health conditions exist across a continuum and address what organisations can do to better support those who do not have a mental health diagnosis.
Recent years have seen an increase in techniques developed for spatial transcriptomics, enabling gene expression patterns to be uncovered within intact, three-dimensional tissues.
The UK will no longer run the REACT study, an 150,000 person analysis of real-time infection, or fund the SIREN study - which monitors COVID levels in healthcare workers.
